
|Videos|September 8, 2016
Diagnosing and Treating MPNs
Author(s)Srdan Verstovsek, MD, PhD
Srdan Verstovsek, MD, PhD, Chief, Section for Myeloproliferative Neoplasms at the University of Texas MD Anderson Cancer Center, Department of Leukemia, discusses identifying and treating different myeloproliferative neoplasms (MPNs).
Advertisement
Srdan Verstovsek, MD, PhD, Chief, Section for Myeloproliferative Neoplasms at the University of Texas MD Anderson Cancer Center, Department of Leukemia, discusses identifying and treating different myeloproliferative neoplasms (MPNs).
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
The Targeted Pulse: Clinical Advancements and FDA News
2
Beyond Chemotherapy: Evaluating the Efficacy of Ribociclib, Letrozole in LGSOC
3
The Strategic Shift in SCLC Management: Bone Marrow Preservation
4
Relacorilant Demonstrates Significant OS in Platinum-Resistant Ovarian Cancer
5



















